Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evonik will acquire PeroxyChem for $625 million

by Michael McCoy
November 8, 2018 | A version of this story appeared in Volume 96, Issue 45

 

Evonik Industries has agreed to acquire PeroxyChem, a producer of hydrogen peroxide and peracetic acid, from the private equity firm One Equity Partners for $625 million. PeroxyChem, which has annual sales of about $300 million, was formed in 2013 when One Equity acquired FMC’s peroxygens business for about $200 million. Evonik, itself one of the world’s largest hydrogen peroxide producers, bought a PeroxyChem plant in the Netherlands in 2015. Evonik now says buying the rest of PeroxyChem will give it a peroxygens business with annual sales of about $800 million. The purchase will also shift Evonik’s business in the direction of more specialized markets such as electronics and food safety, the firm says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.